Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Cannabis is medicine. Just ask the parents of children with seizures

Evan Cole Lewis

Toronto Star

Monday 03 May 2021

I will do my best to respond rather than react to the April 27 opinion piece by Jeff Macintyre titled “Cannabis not ready to be called a medicine, yet.” I am a pediatric neurologist and epilepsy specialist by training, with over 500 adult and pediatric patients in my practice currently being treated with medical cannabis for epilepsy and a broad range of other neurological conditions.

When I first read this piece, I thought how I should reference the results of the five major randomized controlled trials that have been completed in complex, drug-resistant pediatric epilepsy. These studies show that medical cannabis exerts the same degree of antiseizure control as our traditional antiseizure drugs, with comparable side-effect profiles. I thought how it would be helpful to point out that cannabis, in the form of a purified CBD oil called Epidiolex, has been approved as a medical treatment for certain types of epilepsy in children by the FDA in the U.S., the EMA in Europe, and NICE/MHRA in the U.K. I thought I might share stories of the numerous children I have personally treated with unrelenting seizures who, after failing multiple medications for several years, finally responded to cannabis.

However, none of that is needed. Let’s not confuse the subjectivity inherent in the management of pain and anxiety with the clear effects cannabis can produce in drug-resistant epilepsy.

A child is either seizing or they are not. The child is treated with a cannabis oil. The seizures stop. If that is not a medicine, then please tell the parents of these children what it is they are giving their child.

I assume those involved in the cannabis industry are aware that there is a well-defined medical pathway within the Cannabis Act that provides a mechanism by which patients can undergo a consultation with a physician or nurse practitioner and be provided medical direction, oversight, follow-up and medical authorization to receive cannabis. Conflating this with a senior who, under the advice of her son goes to a local recreational dispensary to glean the advice of a budtender to treat her pain, is intentionally misleading.

The opinion posed in the article by Mr. MacIntyre is not only outdated by Canadian standards, but is also dangerous. Producing a consistent cannabis product form batch-to-batch is a challenge faced by licensed producers of cannabis, but that should not serve as rationale to delegitimize cannabis as a medicine. This only works to reinforce inaccessibility, and children should not be the ones to suffer because of our current challenges in manipulating the characteristics of cannabis with perfect consistency.

In the end, the opinion piece does a great disservice to the many children and families struggling with epilepsy and I am grateful the vast majority of Canadians have moved beyond the type of thinking presented in this article. In the future, it is my hope that any leader in the cannabis industry who is offered a platform such as the Toronto Star to describe the medical cannabis landscape considers the whole of their words, and recognizes this issue extends far beyond the problems faced in their own small corner of the cannabis market.

https://www.thestar.com/opinion/contributors/2021/05/03/cannabis-is-medicine-just-ask-the-parents-of-children-with-seizures.html?rf

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!